Medicines and Healthcare products Regulatory Agency (MHRA)
Regulates medicines, medical devices and blood components for transfusion in the UK
(MHRA) is an executive agency of the Department of Health and Social Care in the United Kingdom which is responsible for ensuring that medicines and medical devices work and are acceptably safe.
The MHRA has several independent advisory committees which provide the UK Government with information and guidance on the regulation of medicines and medical devices. There are currently eight such committees.
The MHRA manages the Early Access to Medicines Scheme (EAMS), which was created in 2014 to allow access to medicines prior to market authorisation where there is a clear unmet medical need.
Visit website: https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
medicines-and-healthcare-products-regulatory-agency
Details last updated 30-Apr-2022
People at Medicines and Healthcare products Regulatory Agency (MHRA)
Marc Bailey
Chief Science, Research and Innovation Officer at Medicines and Healthcare products Regulatory Agency (MHRA)
Medicines and Healthcare products Regulatory Agency (MHRA) News
UK's approval of casgevy paves the way for gene-edited treatment of blood disorders
BBC - 16-Nov-2023
Casgevy offers hope for patients with sickle cell disease and beta thalassemia
Read more...MHRA has approved Mounjaro, a diabetes drug that promotes weight loss
GOV.UK - 08-Nov-2023
The drug works by regulating appetite and reducing cravings
Read more...Medicinal mushrooms: A closer look at the science behind the health claims
The Guardian - 29-Oct-2023
More research is needed to confirm the health benefits of mushrooms
Read more...MHRA-trial of new robot that can grow stem cells- to bring new low cost and safe therapies
GOV.UK - 16-Mar-2023
Fully automated Intelligent Cell Processing System to manufacture potentially life-saving treatments
Read more...Update on successful dosing of first patient CLXR-001 by Celixir
GlobeNewswire - 06-Jul-2019
Ongoing clinical trials for heart patients with cellular therapy to cure damaged heart muscles
Read more...Gene Therapy Trial to Restore Sight in Retinitis Pigmentosa
Labiotech - 10-Jan-2018
GenSight using gene therapy and a wearable device to restore sight in patients with retinitis pig...
Read more...